- Active not recruitingPHASE3
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
This study is looking at a new medicine called resmetirom for people with a type of liver scarring called NASH cirrhosis. It aims to see if the medicine can prevent serious liver problems or death over about three years, compared to a dummy pill.
For: NASH · Cirrhosis, LiverUnited States · Belgium · Canada - RecruitingPHASE2
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
This study looks at a medicine called Resmetirom for people who've had a liver transplant and now have a liver condition called MASH. It wants to see if the medicine can help improve their liver health.
For: MASH - Metabolic Dysfunction-Associated SteatohepatitisUnited States · Canada